STATE-OF-THE-ART FACILITIES

WITH COMITTMENT TO QUALITY AND ADHERENCE TO REGULATORY COMPLIANCE

Our Products

39 YEARS IN PHARMACEUTICAL INDUSTRY

multi-speciality drug manufacturing

Our Products
OUR SPECIALITIES

R&D

Our R&D center offers

a plethora of services and

technology.

FACILITIES

A dedicated multi-purpose facility

for full backward integration and

supply stability.

COMPLIANCE

Our facilities are designed to

comply with regulatory and

safety standards.

D&B D-U-N-S REGISTERED
ISO 14001:2004, ISO 9001:2016 and GMP certified
OUR CORE STRENGTHS

AUTOMATION

Our multi-product facilities as well as our teams are readily adaptable and compliant to cater to the wide product requirements of all our existing and future customers.

COMPLETE BACKWARD INTEGRABLE

Our customers’success means our success. We are comitted to provide quality products on time.

RICH LEARNING ENVIRONMENT

Our employees enjoy a rich learning-oriented atmosphere, enabling them to reach global standards and become a benchmark for knowledge.

QUALITY & INTEGRITY

Our approach to Quality and Integrity is transparancy. Our facilities and systems are designed based on QbD principles.

Meet our team

T. S. PRASAD

Mr. Prasad is the Founder & Managing Director of the Almelo Group of Companies. He completed his bachelor degree in commerce (with Honors) from the Indian Institute of Management and Commerce in 1980 and has been leading Almelo towards success ever since.

DR. K. DEO

Dr. Deo, the Executive Director – Technical, earned his Ph.D in Medicinal Chemistry from Central Drug Research Institute (CDRI) in Lucknow, India, in 1989 and Master’s Degree from Agra University in 1985. He has more than 330 global patents to his credit.

ANAND TATAMBHOTLA

Anand, the Executive Director – Operations, holds an MBA from the Judge Business School at the University of Cambridge with a concentration in Health Strategies and is a Chemical Engineering graduate from Indian Institute of Technology (IIT), Bombay.

We are the industry leaders in manufacturing advanced intermediates, Active Pharmaceutical Ingredients (APIs) and specialty fine chemicals.

With a diverse product portfolio coupled with innovative R&D, Almelo boasts of having various reputed domestic and multi-national companies as its customers